Revista clinica espanola最新文献

{"title":"Prevalencia de enfermedad renal crónica en personas con diabetes tipo 1. Estudio multicéntrico en Castilla-La Mancha, España","authors":"M. Gallach Martínez , M. Jara Vidal , A. Ruiz de Assín Valverde , P.J. Pinés Corrales","doi":"10.1016/j.rce.2023.08.005","DOIUrl":"https://doi.org/10.1016/j.rce.2023.08.005","url":null,"abstract":"","PeriodicalId":21223,"journal":{"name":"Revista clinica espanola","volume":"224 2","pages":"Pages 119-121"},"PeriodicalIF":2.9,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139714823","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Carta al editor sobre el artículo «Papel del Doppler de la vena femoral en pacientes con insuficiencia cardiaca aguda: resultados de un estudio multicéntrico prospectivo»","authors":"A. Gil-Rodrigo , M.-J. Luque-Hernández , C. Martínez Buendía , R. Escribano-Castillo","doi":"10.1016/j.rce.2023.09.008","DOIUrl":"10.1016/j.rce.2023.09.008","url":null,"abstract":"","PeriodicalId":21223,"journal":{"name":"Revista clinica espanola","volume":"224 2","pages":"Pages 118-119"},"PeriodicalIF":2.9,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139633466","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Diferencias en función del sexo en las características clínicas y resultados del ensayo clínico CLOROTIC (combinación de diuréticos de asa con tiazidas en la insuficiencia cardiaca descompensada)","authors":"A. Conde-Martel ,&nbsp;J.C. Trullàs ,&nbsp;J.L. Morales-Rull ,&nbsp;J. Casado ,&nbsp;M. Carrera-Izquierdo ,&nbsp;M. Sánchez-Marteles ,&nbsp;P. Llácer ,&nbsp;P. Salamanca-Bautista ,&nbsp;L. Manzano ,&nbsp;F. Formiga","doi":"10.1016/j.rce.2023.11.011","DOIUrl":"https://doi.org/10.1016/j.rce.2023.11.011","url":null,"abstract":"<div><h3>Aims</h3><p>The addition of hydrochlorothiazide (HCTZ) to furosemide improved the diuretic response in patients with acute heart failure (AHF) in the CLOROTIC trial. Our aim was to evaluate if there were differences in clinical characteristics and outcomes according to sex.</p></div><div><h3>Methods</h3><p>This is a post hoc analysis of the CLOROTIC trial, including 230 patients with AHF randomized to receive HCTZ or placebo in addition to an intravenous furosemide regimen. The primary and secondary outcomes included changes in weight and patient-reported dyspnoea 72 and 96<!--> <!-->h after randomization, metrics of diuretic response and mortality/rehospitalizations at 30 and 90<!--> <!-->days. The influence of sex on primary, secondary and safety outcomes was evaluated.</p></div><div><h3>Results</h3><p>One hundred and eleven (48%) women were included in the study. Women were older and had higher values of left ventricular ejection fraction. Men had more ischemic cardiomyopathy and chronic obstructive pulmonary disease and higher values of natriuretic peptides. The addition of HCTZ to furosemide was associated to a greatest weight loss at 72/96<!--> <!-->h, better metrics of diuretic response and higher 24-h diuresis compared to placebo without significant differences according to sex (all <em>P</em>-values for interaction were not significant). Worsening renal function occurred more frequently in women (OR: 8.68; 95%<!--> <!-->CI: 3.41-24.63) than men (OR: 2.5; 95%<!--> <!-->CI: 0.99-4.87), <em>P</em> <!-->=<!--> <!-->.027. There were no differences in mortality or rehospitalizations at 30/90<!--> <!-->days.</p></div><div><h3>Conclusion</h3><p>Adding HCTZ to intravenous furosemide is an effective strategy to improve diuretic response in AHF with no difference according to sex, but worsening renal function was more frequent in women.</p></div>","PeriodicalId":21223,"journal":{"name":"Revista clinica espanola","volume":"224 2","pages":"Pages 67-76"},"PeriodicalIF":2.9,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139714889","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Evaluación de la eficacia de la N-acetilcisteína y la bromhexina en comparación con la atención estándar en la prevención de la hospitalización de pacientes ambulatorios con COVID-19: un ensayo clínico aleatorizado doble ciego","authors":"A. Eslami-Ghayour ,&nbsp;S. Nazari ,&nbsp;F. Keramat ,&nbsp;F. Shahbazi ,&nbsp;A. Eslami-Ghayour","doi":"10.1016/j.rce.2023.12.002","DOIUrl":"https://doi.org/10.1016/j.rce.2023.12.002","url":null,"abstract":"<div><h3>Introduction and aim</h3><p>Since its emergence in December 2019, the coronavirus disease caused by the severe acute respiratory syndrome coronavirus<!--> <!-->2 has become a global emergency, spreading rapidly worldwide. In response to the early referral of these patients to outpatient health centers, we decided to seek more effective treatments in the early stages of their referral. This study aims to prevent both the progression and deterioration of the physical conditions of COVID-19 patients, reduce the rate of referrals, and mitigate the risks of hospitalization and death.</p></div><div><h3>Material and methods</h3><p>Conducted at Dibaj Therapeutic Center, Hamadan City, Iran, a double-blind randomized controlled trial encompassed 225 COVID-19 patients from April to September 2022. Ethical approval was obtained from Hamadan University of Medical Sciences (Approval No.: IR.UMSHA.REC.1400.957), with the protocol registered in the Iranian Registry of Clinical Trials (Registration No.: IRCT20220302054167N1). In this study, we included patients who tested positive for COVID-19 PCR and were symptomatic, excluding those who were pregnant or had received a COVID-19 vaccine. Patients with oxygen saturation above 92% were allocated to three groups: Group<!--> <!-->A received N-acetylcysteine, Group<!--> <!-->B received Bromhexine, and Group<!--> <!-->C received standard care. Follow-ups on oxygen levels, symptoms, and hospitalization needs were conducted on days 7 and 14, with hospitalized patients monitored for one month post-hospitalization.</p></div><div><h3>Results</h3><p>The study found that both N-acetylcysteine and Bromhexine can effectively reduce hospitalization rates and mortality and shorten the duration of hospitalization. The third visit of patients who received N-acetylcysteine showed an increase of 1.33% in oxygen saturation compared to their first visit, and in patients who received Bromhexine, this increase was 1.19%. The mortality rate was 9.33% in the control group and zero in both groups of patients who received medication.</p></div><div><h3>Conclusion</h3><p>In conclusion, the results of this study indicate that N-acetylcysteine and bromhexine may be effective in the treatment of patients with positive COVID-19, with a lower hospitalization rate, shorter hospitalization, faster recovery time, and reduced mortality compared to the control group.</p></div>","PeriodicalId":21223,"journal":{"name":"Revista clinica espanola","volume":"224 2","pages":"Pages 86-95"},"PeriodicalIF":2.9,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139714890","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Cuidados paliativos geriátricos en demencia avanzada","authors":"D.S. Marín-Medina ,&nbsp;H. Bautista-Mier ,&nbsp;D.M. Perilla-Orozco ,&nbsp;J.A. Sánchez-Duque","doi":"10.1016/j.rce.2023.09.009","DOIUrl":"10.1016/j.rce.2023.09.009","url":null,"abstract":"","PeriodicalId":21223,"journal":{"name":"Revista clinica espanola","volume":"224 2","pages":"Pages 117-118"},"PeriodicalIF":2.9,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139634910","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Factores predictivos del riesgo de fractura de cadera osteoporótica en octogenarios","authors":"A. Capdevila-Reniu ,&nbsp;M. Navarro-López ,&nbsp;V. Sapena ,&nbsp;A.I. Jordan ,&nbsp;M. Arroyo-Huidobro ,&nbsp;A. López-Soto","doi":"10.1016/j.rce.2023.11.010","DOIUrl":"10.1016/j.rce.2023.11.010","url":null,"abstract":"<div><h3>Objective</h3><p>This study aims to identify the risk factors associated with osteoporotic hip fractures in octogenarians and seeks to refine primary prevention strategies for these fractures.</p></div><div><h3>Material and methods</h3><p>We conducted a case–control study involving individuals aged 79 years and older with hip fractures, comparing them to age- and sex-matched controls without a history of hip fractures. We collected epidemiological, clinical, anthropometric, and analytical factors. We evaluated the presence of osteoporosis using bone densitometry. We defined sarcopenia according the European Working Group on Sarcopenia in Older People criteria (EWGSOP2).</p></div><div><h3>Results</h3><p>Ninety-five patients per group were analyzed, with a mean age of 82 years, of which 74% were women. The multivariate analysis included statistically significant factors found in the univariate analysis (<em>P</em><span>&lt;</span>.05). These factors included the Barthel Index, nutritional assessment using the CONUT tool, folic acid, vitamin D deficiency, presence of previous fractures, loss of visual acuity, bicipital circumference, sarcopenia, and osteoporosis (densitometry in the neck of the femur). The nutritional state (OR: 0.08 [0.01–0.61]), the folic acid levels (OR 0.32 [0.1–1]), and a loss of visual acuity (OR 33.16 [2.91–377.87]) were the independent risk factors associated with hip fracture.</p></div><div><h3>Conclusions</h3><p>The assessment of nutritional status in elderly patients, coupled with a comprehensive geriatric assessment, represents easily reproducible and cost-effective tools. These tools can effectively aid in identifying individuals at risk of hip fractures, thereby contributing to more targeted and efficient preventive measures.</p></div>","PeriodicalId":21223,"journal":{"name":"Revista clinica espanola","volume":"224 2","pages":"Pages 77-85"},"PeriodicalIF":2.9,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139635787","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Polimorfismos de los genes CCR5, IL-6, IFN-γ e IL-10 en pacientes cubanos con VIH/sida","authors":"D. Hernández Requejo ,&nbsp;Y. de Armas ,&nbsp;E. Iglesias ,&nbsp;H.M. Díaz ,&nbsp;R. Gravier ,&nbsp;M.C. Godínez López ,&nbsp;L. Fonte ,&nbsp;M. Plascencia-Cruz ,&nbsp;K. Pacheco-Quijano ,&nbsp;J. Palomares ,&nbsp;H.R. Pérez-Gómez ,&nbsp;A. Plascencia-Hernández ,&nbsp;E.J. Calderón","doi":"10.1016/j.rce.2023.12.003","DOIUrl":"https://doi.org/10.1016/j.rce.2023.12.003","url":null,"abstract":"<div><h3>Introduction</h3><p>Genetic studies have shown associations of several single nucleotide polymorphisms (SNP) with different rates of progression and variation in susceptibility to HIV infection. This study aimed to estimate the frequency of ccr5Δ32, IL-6-174G/C, IFN-γ+874T/A and IL-10-1082A/G polymorphisms in Cuban HIV-infected patients and a group of sero-discordant couples to assess their influence on risk and disease progression.</p></div><div><h3>Methods</h3><p>A cross-sectional study was carried out on 120 subjects registered at the Institute of Tropical Medicine «Pedro Kour» (IPK) and the Ameijeiras Hospital from June 2018 until December 2019. The amplification of fragments of the <em>ccr5</em>, <em>IL-6</em>, <em>IFN-γ</em> and <em>IL-10</em> genes was performed by polymerase chain reaction followed by identification of polymorphisms using the restriction fragment length polymorphism analysis for IL-6 with the restriction enzymes Nla III. Amplification refractory mutation system was used for <em>IFN-γ</em> and <em>IL-10</em> genes.</p></div><div><h3>Results</h3><p>The allelic and genotypic distributions of the genes <em>ccr5</em>, <em>IL-6</em>, <em>IFN-γ</em> and <em>IL-10</em> did not differ significantly between the two groups. Cell counts and plasma viral load values did not differ significantly between genotypes of the <em>ccr5</em>, <em>IL-6</em>, <em>IFN-γ</em> and <em>IL-10</em> genes. Only the IL-6 GC genotype was associated with higher viral load values. The combination of alleles of the four considered SNPs showed a highly significant increase in the risk of HIV infection for one of them, but with a very low frequency (&lt;<!--> <!-->1%).</p></div><div><h3>Conclusion</h3><p>This study contributes to evaluating the frequency of these polymorphisms and their influence on biomarkers of the progression of HIV infection in the Cuban HIV-population.</p></div>","PeriodicalId":21223,"journal":{"name":"Revista clinica espanola","volume":"224 2","pages":"Pages 96-104"},"PeriodicalIF":2.9,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139714822","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Resumen ejecutivo sobre la optimización del abordaje multidisciplinar e integrado de la polimialgia reumática y la arteritis de células gigantes en la Comunidad de Madrid","authors":"A. González García ,&nbsp;C. del Arco ,&nbsp;D. Lucas Fernández ,&nbsp;M. Frías-Vargas ,&nbsp;M. Guillán ,&nbsp;M. Méndez-Bailón ,&nbsp;M. Ruiz Grinspan ,&nbsp;A.C. Aguado-Castaño ,&nbsp;J. Fraile Maya ,&nbsp;G. Latorre González ,&nbsp;S. Castañeda","doi":"10.1016/j.rce.2023.11.008","DOIUrl":"10.1016/j.rce.2023.11.008","url":null,"abstract":"<div><p>Polymyalgia rheumatica and giant cell arteritis can be a medical emergency in which a delay in correct diagnosis and therapeutic management can cause serious complications.</p><p>With the aim of improving the care of patients with these pathologies in the Community of Madrid, a study was designed to identify the causes and possible solutions to address the problems related to the diagnosis of these pathologies.</p><p>After the analysis, 11 areas of improvement related to four different aspects of the care process were identified: coordination and protocols, equipment, training and awareness of pathologies, and patient experience. Of all the areas identified, it was considered a priority to resolve those related to the generation of protocols for the comprehensive management of the pathologies, which include all the specialties and levels of care involved. Another crucial aspect is the increase in the degree of clinical suspicion of these pathologies.</p></div>","PeriodicalId":21223,"journal":{"name":"Revista clinica espanola","volume":"224 1","pages":"Pages 48-56"},"PeriodicalIF":2.9,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139454010","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Asociación entre la velocidad estimada de onda de pulso y la muerte por todas las causas en pacientes con insuficiencia cardiaca","authors":"X. Yuan ,&nbsp;C. Chen ,&nbsp;J. Mao ,&nbsp;W. Bao ,&nbsp;C. Chen ,&nbsp;T. Xu","doi":"10.1016/j.rce.2023.11.009","DOIUrl":"https://doi.org/10.1016/j.rce.2023.11.009","url":null,"abstract":"<div><h3>Background</h3><p>Arteriosclerosis has been proven to be a risk factor for the development of heart failure and readmission. ePWV is a novel non-invasive and simple indicator of arterial stiffness, and this study aims to investigate its relationship with all-cause mortality rate in patients with heart failure.</p></div><div><h3>Methods</h3><p>This study is a cohort study that included 1272 patients with heart failure from NHANES data from 1999 to 2018. The ePWV was divided into three groups, and the cumulative mortality rate of heart failure patients was calculated using KM survival curves. The relationship between ePWV and all-cause mortality rate in heart failure patients was represented by a smoothed curve fitting. COX regression analysis was used to assess the association between ePWV and all-cause mortality rate in heart failure patients.</p></div><div><h3>Results</h3><p>The average age of the study population was 67.8<!--> <!-->±<!--> <!-->12.6 years, with 862 males and 650 females. During the 12-month follow-up period, there were 790 cases of all-cause mortality. Cox regression analysis was used to validate the relationship between ePWV and all-cause mortality rate in patients with heart failure. Patients with higher levels of ePWV tended to have a higher all-cause mortality rate. After adjustment for multiple factors, an increase in ePWV was positively associated with all-cause mortality rate (HR<!--> <!-->=<!--> <!-->1.17, 95% confidence interval [CI]: 1.12-1.22). Compared to the lowest tertile, the multivariable-adjusted HR and 95%<!--> <!-->CI for the highest tertile of ePWV were 1.81 (95%<!--> <!-->CI: 1.45-2.27). Additionally, a smoothed curve fitting was used to observe the relationship between ePWV and mortality rate, where the curve demonstrated a positive correlation between ePWV and all-cause mortality rate. Furthermore, KM survival curves indicated that all-cause mortality rate increased with the increase in ePWV. Subgroup analysis suggested a correlation between ePWV and mortality rate.</p></div><div><h3>Conclusion</h3><p>Our study shows that ePWV is positively associated with all-cause mortality in patients with heart failure.</p></div>","PeriodicalId":21223,"journal":{"name":"Revista clinica espanola","volume":"224 1","pages":"Pages 17-23"},"PeriodicalIF":2.9,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139480010","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Impacto de las medidas de aislamiento estricto, actividad quirúrgica y uso de antibióticos en la infección por Clostridioides difficile durante la COVID-19","authors":"J. Ena ,&nbsp;C. Martinez-Peinado ,&nbsp;V. Valls","doi":"10.1016/j.rce.2023.09.007","DOIUrl":"https://doi.org/10.1016/j.rce.2023.09.007","url":null,"abstract":"","PeriodicalId":21223,"journal":{"name":"Revista clinica espanola","volume":"224 1","pages":"Pages 65-66"},"PeriodicalIF":2.9,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139480014","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}